Alternatively Activated Macrophages in Types 1 and 2 Diabetes
Luis Terrazas
Mediators of Inflammation, 2012
View PDFchevron_right
Proinflammatory and atherogenic activity of monocytes in Type 2 diabetes
Tadeusz Dobosz
Journal of Diabetes and its Complications, 2010
View PDFchevron_right
Monocyte-derived macrophages from men and women with Type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls
Ian Puddey, David Joyce, Vijay Panicker
Diabetes Research and Clinical Practice, 2007
View PDFchevron_right
Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis
Jocelyn Cervantes
Frontiers in Cardiovascular Medicine, 2023
View PDFchevron_right
The role of immune and inflammatory processes in the development of macrovascular disease in diabetes
Maria Lopes-virella
Frontiers in Bioscience, 2003
View PDFchevron_right
Diabetic state induces lipid loading and altered expression and secretion of lipoprotein lipase in human monocyte-derived macrophages
Anca Dobrian
Atherosclerosis, 2000
View PDFchevron_right
Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes
Arno Hänninen
The review of diabetic studies : RDS, 2010
View PDFchevron_right
Diabetes and inflammation: Fundamental aspects and clinical implications
Cyril John C. Garcia
Diabetes & Metabolism, 2010
View PDFchevron_right
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Georgia Vogiatzi
European Cardiology Review, 2019
View PDFchevron_right
Activation of Peripheral Blood CD14+ Monocytes Occurs in Diabetes
Elisabeth Trimble
Diabetes, 2005
View PDFchevron_right
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects
Francesco Piarulli
Oxidative medicine and cellular longevity, 2017
View PDFchevron_right
Diabetes-induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids
chi trieu
Life Sciences, 1998
View PDFchevron_right
Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice
Fabio Naro
PLOS ONE, 2015
View PDFchevron_right
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
Bernard Portha
Proceedings of the National Academy of Sciences, 2009
View PDFchevron_right
Monocyte-mediated inflammation and cardiovascular risk factors in type 2 diabetes mellitus: A systematic review and meta-analysis of pre-clinical and clinical studies
kabelo Mokgalaboni
View PDFchevron_right
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
Chris Kalofoutis, Christina Piperi
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Proinflammatory Cytokines Inducing Th 17 Diabetes Spontaneously Secrete Monocytes from Patients with Type 1 A
Khadir Raddassi
2009
View PDFchevron_right
Endothelium, inflammation, and diabetes
Paresh Dandona
Current Diabetes Reports, 2002
View PDFchevron_right
Macrophage inflammatory state in Type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid
Rui Curi
Clinical Science, 2021
View PDFchevron_right
Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term
Wenjun Ding
Journal of Molecular Medicine, 2008
View PDFchevron_right
Inflammation and Diabetes
Dr Madhukar Saxena
Interdisciplinary Journal of Microinflammation, 2014
View PDFchevron_right
Release of TNF-alpha From In Vitro-Stimulated Monocytes is Negatively Associated with Serum Levels of Apolipoprotein B in Patients with Type 2 Diabetes
R. Seljelid
Scandinavian Journal of Immunology, 2004
View PDFchevron_right
Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells
Wassim Elyaman
The Journal of Immunology, 2009
View PDFchevron_right
Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
Jacek Kubiak
Journal of Diabetes & Metabolic Disorders, 2020
View PDFchevron_right
Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes
Mauro Marrocos
Clinical and Experimental Immunology, 2006
View PDFchevron_right
Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice
David Alleva
Diabetes, 2000
View PDFchevron_right
Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse
soon-cheol Hong
International Immunology, 2006
View PDFchevron_right
Glucose metabolism controls disease-specific signatures of macrophage effector functions
David Harrison
JCI insight, 2018
View PDFchevron_right
Effect of Exposure of Human Monocyte-Derived Macrophages to High, versus Normal, Glucose on Subsequent Lipid Accumulation from Glycated and Acetylated Low-Density Lipoproteins
Fatemeh Moheimani
Experimental Diabetes Research, 2011
View PDFchevron_right
Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy
Fusanori Nishimura
Diabetes Research and Clinical Practice, 2010
View PDFchevron_right